Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.
BuchGebunden
332 Seiten
Englisch
Springererschienen am27.08.20221st ed. 2022
Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders.mehr
Verfügbare Formate
BuchGebunden
EUR213,99
BuchKartoniert, Paperback
EUR213,99
E-BookPDF1 - PDF WatermarkE-Book
EUR213,99

Produkt

KlappentextPsychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders.
Zusammenfassung
Summarizes the state of the science of safety and efficacy of psychedelic therapies

Reviews theoretical models and approaches to psychedelic therapies

Treats both theoretical and practical aspects of psychedelic therapies
Details
ISBN/GTIN978-3-031-12183-8
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2022
Erscheinungsdatum27.08.2022
Auflage1st ed. 2022
ReiheCurrent Topics in Behavioral Neurosciences
Seiten332 Seiten
SpracheEnglisch
IllustrationenVIII, 332 p. 100 illus., 30 illus. in color.
Artikel-Nr.16567166
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Dosing psychedelics and MDMA.- Psychedelic Group Therapy.- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies.- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults.- Foundations for Training Psychedelic Therapists.- Ayahuasca for the Treatment of Depression.- Psilocybin for the Treatment of Depression.- Ketamine for the Treatment of Depression.- The Potential of Psychedelics for End of Life and Palliative Care.- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action.- Psilocybin for Tobacco Use Disorder.- Psychedelic Drugs as Anti-Inflammatory Agents.- Psilocybin for the Treatment of Obsessive-Compulsive Disorder.- Psilocybin for the Treatment of Headache and Pain Disorders.- Psilocybin for the Treatment of Neurodegenerative Disorders.- Psilocybin for Trauma-Related Disorders.mehr

Schlagworte